|

AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention

RECRUITINGN/ASponsored by Brigham and Women's Hospital
Actively Recruiting
PhaseN/A
SponsorBrigham and Women's Hospital
Started2024-07-31
Est. completion2027-06-01
Eligibility
Age40 Years – 75 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06235112

Summary

AI INFORM is a multicenter randomized trial that will test the hypothesis that providing clinicians information on the presence and amount of coronary artery calcifications (CAC), will result in initiation or intensification of preventive therapies. The study will use a cloud-based artificial intelligence (AI) platform (Nanox.AI) that can analyze non contrast chest CT and estimate the amount of CAC.

Eligibility

Age: 40 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients aged between 40-75 with prior chest CT within last 3 years

Exclusion Criteria:

* Prior coronary artery disease
* Prior cancer
* Other life-limiting condition

Conditions2

Coronary Artery DiseaseHeart Disease

Locations1 site

Brigham and Women's Hospital
Boston, Massachusetts, 02445
Daniel Huck, MDdhuck@bwh.harvard.edu

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.